Prof. Dr. Ana Olga Mocumbi (MD, PhD, FESC) is a cardiologist with a particular interest in neglected cardiovascular diseases specifically rheumatic heart disease, cardiomyopathies, heart failure in young people, and women’s cardiovascular health. She is Professor of Cardiology at the Eduardo Mondlane University (UEM), Mozambique and is Head of the Division of Non-Communicable Diseases at the National Public Health Institute (INS), at the Ministry of Health in Mozambique.
Dr. Mocumbi obtained an MD in 1992 at UEM. She worked in several rural areas of Mozambique from 1992 – 1997 acting as a general practitioner and health manager, gaining experience on management of National Control Programs for major endemic diseases.
Her post-graduate training in cardiology was done in Mozambique (Central Hospital of Maputo and Instituto do Coração) and France (Hospital Necker-Enfants Malades). She holds a Diploma in Pediatric Cardiology from the University René Descartes, Paris V – France.
Dr. Mocumbi worked as a Research Assistant at the Imperial College London (from 2004 until 2008) where she obtained her PhD investigating the Epidemiology of Neglected Cardiovascular Diseases. Under this program she launched a research project on Endomyocardial Fibrosis, which included large-scale community-based studies and clinical research in a rural endemic area of Mozambique (Inharrime), involving collaboration with the Heart Science Centre and Magdi Yacoub Research Institute in the United Kingdom.
Dr. Mocumbi is involved in several local and international research projects and partnerships including international registries and clinical trials. She is Editor of the Cardiovascular Diagnosis and Therapy Journal and has published original papers in peer-reviewed journals and didactic publications.
She is currently Vice President of the Pan African Society of Cardiology (PASCAR) South Region (and Member of the PASCAR Taskforce on Hypertension), Co-Leader of the Pulmonary Vascular Research Institute for the Sub-Saharan Region and Member of the World Heart Federation’s Scientific Policy and Advocacy Committee.